Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
Top Cited Papers
Open Access
- 6 August 2014
- Vol. 69 (12), 1098-1104
- https://doi.org/10.1136/thoraxjnl-2014-205285
Abstract
Background Malignant pleural effusion (MPE) causes debilitating breathlessness and predicting survival is challenging. This study aimed to obtain contemporary data on survival by underlying tumour type in patients with MPE, identify prognostic indicators of overall survival and develop and validate a prognostic scoring system. Methods Three large international cohorts of patients with MPE were used to calculate survival by cell type (univariable Cox model). The prognostic value of 14 predefined variables was evaluated in the most complete data set (multivariable Cox model). A clinical prognostic scoring system was then developed and validated. Results Based on the results of the international data and the multivariable survival analysis, the LENT prognostic score (pleural fluid lactate dehydrogenase, Eastern Cooperative Oncology Group (ECOG) performance score (PS), neutrophil-to-lymphocyte ratio and tumour type) was developed and subsequently validated using an independent data set. Risk stratifying patients into low-risk, moderate-risk and high-risk groups gave median (IQR) survivals of 319 days (228–549; n=43), 130 days (47–467; n=129) and 44 days (22–77; n=31), respectively. Only 65% (20/31) of patients with a high-risk LENT score survived 1 month from diagnosis and just 3% (1/31) survived 6 months. Analysis of the area under the receiver operating curve revealed the LENT score to be superior at predicting survival compared with ECOG PS at 1 month (0.77 vs 0.66, pConclusions The LENT scoring system is the first validated prognostic score in MPE, which predicts survival with significantly better accuracy than ECOG PS alone. This may aid clinical decision making in this diverse patient population.Keywords
This publication has 24 references indexed in Scilit:
- Inflammation-Based Prognostic Indices in Malignant Pleural MesotheliomaJournal of Thoracic Oncology, 2012
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyEuropean Journal Of Cancer, 2011
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic TherapyClinical Cancer Research, 2010
- Prognostic Factors for Survival after Surgical Palliation of Malignant Pleural EffusionJournal of Thoracic Oncology, 2010
- Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010Thorax, 2010
- Predictors of mortality within three months in the patients with malignant pleural effusionEuropean Journal of Internal Medicine, 2010
- Prognostic significance of pleural fluid data in patients with malignant effusionEuropean Journal of Internal Medicine, 2008
- The evidence on the effectiveness of management for malignant pleural effusion: a systematic reviewEuropean Journal of Cardio-Thoracic Surgery, 2006
- Management of Malignant Pleural EffusionsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Predicting Survival in Patients With Recurrent Symptomatic Malignant Pleural EffusionsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2000